Skip to main content

Millipore Shares Soar on Rumors of a $6B Buyout Bid from Thermo Fisher

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Shares of Millipore climbed as high as $102.91 — a 44 percent rise from its Friday closing price of $71.34 — after a report from Bloomberg claimed that Thermo Fisher Scientific has made an unsolicited $6 billion bid to acquire the firm.

A Thermo Fisher spokesperson said the firm would not comment on the "rumor," and Millipore did not respond to a request for comment.

However, Reuters reported later in the day that a source had confirmed for them that Thermo Fisher had made the offer. Both news agencies said that Millipore has hired Goldman Sachs as a financial advisor in response to the bid.

In Monday afternoon trade, shares of Millipore pulled back some but were still up 21 percent at $86.17 on the New York Stock Exchange.

Millipore has a market cap of around $4.9 billion and recently reported full-year 2009 revenues of $1.65 billion.

Thermo Fisher earlier this month reported 2009 revenues of $10.11 billion, and it currently has a market cap of around $19.5 billion.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.